Global HIV statistics
- 39 million [33.1 million–45.7 million] people globally were living with HIV in 2022.
- 1.3 million [1 million–1.7 million] people became newly infected with HIV in 2022.
- 630 000 [480 000–880 000] people died from AIDS-related illnesses in 2022.
- 29.8 million people were accessing antiretroviral therapy in 2022.
- 85.6 million [64.8 million–113.0 million] people have become infected with HIV and 40.4 million [32.9 million–51.3 million] people have died from AIDS-related illnesses since the start of the epidemic.
People living with HIV
- In 2022, there were 39 million [33.1 million–45.7 million] people living with HIV.
- 37.5 million [31.8 million–43.6 million] adults (15 years or older).
- 1.5 million [1.2 million–2.1 million] children (0–14 years).
- 53% of all people living with HIV were women and girls.
- 86% [73– >98%] of all people living with HIV knew their HIV status in 2022.
People living with HIV accessing antiretroviral therapy
- At the end of December 2022, 29.8 million people (76% [65–89%] of all people living with HIV) were accessing antiretroviral therapy, up from 7.7 million in 2010.
- 77% [65–90%] of adults aged 15 years and older had access to treatment; however, just 57% [44–78%] of children aged 0–14 years had access.
- 82% [69–95%] of women aged 15 years and older had access to treatment; however, just 72% [60–84%] of men aged 15 years and older had access.
- 82% [64–98%] of pregnant women living with HIV had access to antiretroviral medicines to prevent transmission of HIV to their child in 2022.
- 9.2 million people living with HIV did not have access to antiretroviral treatment in 2022.
New HIV infections
- New HIV infections have been reduced by 59% since the peak in 1995.
- In 2022, 1.3 million [1 million–1.7 million] people were newly infected with HIV, compared to 3.2 million [2.5 million–4.3 million] people in 1995.
- Women and girls accounted for 46% of all new infections in 2022.
- Since 2010, new HIV infections have declined by 38%, from 2.1 million [1.6 million–2.8 million] to 1.3 million [1 million–1.7 million] in 2022.
- Since 2010, new HIV infections among children have declined by 58%, from 310 000 [210 000–490 000] in 2010 to 130 000 [90 000–210 000] in 2022.
AIDS-related deaths
- AIDS-related deaths have been reduced by 69% since the peak in 2004 and by 51% since 2010.
- In 2022, around 630 000 [480 000–880 000] people died from AIDS-related illnesses worldwide, compared to 2.0 million [1.5 million–2.8 million] people in 2004 and 1.3 million [970 000–1.8 million] people in 2010.
- AIDS-related mortality has declined by 55% among women and girls and by 47% among men and boys since 2010.
Women and girls
- Globally 46% of all new HIV infections were among women and girls in 2022.
- In sub-Saharan Africa, adolescent girls and young women accounted for more than 77% of new infections among young people aged 15-24 years in 2022.
- In sub-Saharan Africa adolescent girls and young women (aged 15-24 years) in were more than three times as likely to acquire HIV than their male peers in 2022.
- Every week, 4000 adolescent girls and young women aged 15–24 years became infected with HIV globally in 2022. 3100 of these infections occurred in sub-Saharan Africa.
- Only about 42% of districts with high HIV incidence in sub-Saharan Africa had dedicated HIV prevention programmes for adolescent girls and young women in 2021.
Key populations
- Globally, median HIV prevalence among the adult population (ages 15-49) was 0.7%. However median prevalence was higher among key populations:
- 2.5% among sex workers
- 7.5% among gay men and other men who have sex with men
- 5.0% among people who inject drugs
- 10.3% among transgender persons
- 1.4% among people in prisons.
Testing and treatment targets (95–95–95)
- In 2022, 86% [73– >98%] of all people living with HIV knew their HIV status. Among people who knew their status, 89% [75– >98%] were accessing treatment. And among people accessing treatment, 93% [79– >98%] were virally suppressed.
- Among all people living with HIV, 86% [73– >98%] knew their status, 76% [65–89%] were accessing treatment and 71% [60–83%] were virally suppressed in 2022.
- Five countries— Botswana, Eswatini, Rwanda, the United Republic of Tanzania, and Zimbabwe had achieved the 95-95-95 targets by 2022.
Funding
- A total of US$ 20.8 billion (constant 2019 US$) was available for HIV programmes in low- and middle-income countries in 2022––2.6% less than in 2021 and well short of the US$ 29.3 billion needed by 2025.
- Around 60% of resources available in 2022 were sourced domestically, compared with around 50% in 2010.
- The reduction in resources available for HIV in 2022 is due to declines in both international and domestic funding. The US$ 8.3 billion of external HIV funding in 2022 was 3% lower than in 2021. At the same time, domestic funding is diminishing.
- Bilateral funding from the United States Government constituted 58% of all international assistance for HIV, while disbursements from the Global Fund to Fight AIDS, Tuberculosis and Malaria accounted for about 29%. Other international donors contributed the remainder, but that share has diminished considerably, from approximately US$ 3 billion in 2010 to US$ 1.2 billion in 2022, a 61% decrease.
- In 2022, there was an estimated 90% funding gap for HIV prevention programmes among people from key populations, compared with the funding needed by 2025.
Download the full version to view regional statistics, global and regional data